New insights into how prostate cancer protects itself from latest therapies after researchers uncover the gene responsible for this resistance while investigating new drug that circumvents these protective mechanisms.

Dr. Barry Dworkin

Medical Mythbusting Commentary for November 28, 2022

New insights into how prostate cancer protects itself from latest therapies after researchers uncover the gene responsible for this resistance while investigating new drug that circumvents these protective mechanisms. Play Now | Play in Popup | Download

Source:
Drug triggers immune cells to attack prostate cancer

Reference:
Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance.

Related posts:

  1. Genes research offers cancer treatment hope
  2. Bowel cancer treatment strategy developed using molecular oncology
  3. Ottawa Hospital creates new Medical Oncology lab leading to development of pharmacogenomic medicine for the region
  4. McGill University study shows that a shortened course of radiation therapy is safe and effective for men with high-risk prostate cancer
Bitnami